Literature DB >> 10432052

Seroprevalence of Helicobacter pylori among Egyptian newborns and their mothers: a preliminary report.

S Bassily1, R W Frenck, E W Mohareb, T Wierzba, S Savarino, E Hall, A Kotkat, A Naficy, K C Hyams, J Clemens.   

Abstract

Helicobacter pylori is one of the most common human bacterial infections in the world and children in the developing countries acquire H. pylori infection early in life. We prospectively evaluated the prevalence of serum antibodies to H. pylori in a cohort of pregnant women and their offspring. Mothers' sera were collected during the third trimester of pregnancy and sera from their offspring were collected when they were 7-9 months and 18 months of age. Pylori-Stat, a commercially available ELISA kit, was used to detect antibodies to H. pylori in the serum of the subjects tested. Sera from 169 mothers were available for testing and 88% of these samples were positive for anti-H. pylori IgG. Of the 169 children tested, 13% of the infants 7-9 months of age and 25% of the children 18 months of age had serologic evidence of H. pylori infection. These data indicate that infection with H. pylori is common in Egypt and acquisition of infection occurs at a very young age.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432052     DOI: 10.4269/ajtmh.1999.61.37

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

1.  Helicobacter pylori seroprevalence in asymptomatic pregnant women in France.

Authors:  N Kalach; J Desramé; C Bonnet; P Commegeille; D Couturier; S Chaussade; P Hance; C Dupont; J Raymond
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Helicobacter pylori: clonal population structure and restricted transmission within families revealed by molecular typing.

Authors:  S R Han; H C Zschausch; H G Meyer; T Schneider; M Loos; S Bhakdi; M J Maeurer
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

Review 3.  Epidemiology of Helicobacter pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean Region: a systematic review of prevalence and risk factors.

Authors:  Ahad Eshraghian
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

4.  Helicobacter pylori: a poor man's gut pathogen?

Authors:  Mohammed Mahdy Khalifa; Radwa Raed Sharaf; Ramy Karam Aziz
Journal:  Gut Pathog       Date:  2010-03-31       Impact factor: 4.181

Review 5.  Helicobacter pylori and pregnancy-related disorders.

Authors:  Simona Cardaropoli; Alessandro Rolfo; Tullia Todros
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

6.  Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt.

Authors:  May Sherif; Zaynab Mohran; Hanan Fathy; David M Rockabrand; Patrick J Rozmajzl; Robert W Frenck
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

7.  Premastication: the second arm of infant and young child feeding for health and survival?

Authors:  Gretel H Pelto; Yuanyuan Zhang; Jean-Pierre Habicht
Journal:  Matern Child Nutr       Date:  2010-01       Impact factor: 3.092

8.  Braf, Kras and Helicobacter pylori epigenetic changes-associated chronic gastritis in Egyptian patients with and without gastric cancer.

Authors:  Dina Sabry; Rasha Ahmed; Sayed Abdalla; Wael Fathy; Ahmed Eldemery; Azza Elamir
Journal:  World J Microbiol Biotechnol       Date:  2016-04-27       Impact factor: 3.312

9.  Association between Severity of Liver Disease, Frequency of Helicobacter pylori Infection, and Degree of Gastric Lesion in Egyptian Patients with Hepatitis B Virus Infection.

Authors:  Amal A Mohamed; Amal A Elshimy; Abir O El Sadik; Elham Ezzat; Mona Nasar; Shereen S M Elshaer; Moataz M Sayed
Journal:  Am J Trop Med Hyg       Date:  2018-01       Impact factor: 2.345

10.  Systematic review of birth cohort studies in South East Asia and Eastern Mediterranean regions.

Authors:  Rachel McKinnon; Harry Campbell
Journal:  J Glob Health       Date:  2011-06       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.